# A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas

> **NCT01240304** · PHASE2 · TERMINATED · sponsor: **University of Arkansas** · enrollment: 10 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Gemcitabine
- **RADIATION:** Radiation therapy
- **PROCEDURE:** pancreaticoduodenectomy

## Key facts

- **NCT ID:** NCT01240304
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** no subjects enrolled
- **Last updated:** 2019-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01240304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01240304, "A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01240304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*